Global Medical Director, Rare Bone & Endocrine Disorders
Alexion Pharmaceuticals, Inc.Barcelona, Catalonia, Spain
Posted April 7, 2026
Full Time
About the Company
Alexion, AstraZeneca Rare Disease was created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. by AstraZeneca. For more than 30 years, Alexion’s mission has been to transform the lives of people affected by rare diseases through the development and delivery of innovative medicines, supportive technologies, and healthcare services. Dedicated to continuing its mission as part of AstraZeneca, Alexion recognizes that patients and caregivers are people first, and by understanding their experiences, Alexion is better able to serve their unique needs. Alexion’s pioneering legacy in rare disease is rooted in being the first to translate the complex biology of the complement system into novel medicines. Alexion pushes boundaries to accelerate discovery of life-changing medicines. Headquartered in Boston, Massachusetts, Alexion has offices around the world and continues to expand its reach to benefit more people globally. GL/NP/0116 GL/NP/0095 Community Guidelines: https://bit.ly/39x9gqy
Job Description
The Global Medical Director will lead and contribute to the development and execution of the strategy in Rare Bone & Endocrine Disorders, providing strong scientific and medical expertise with an in-depth understanding of the disease area and unmet medical needs.
Requirements
- Representing GMA at the relevant Global Program Teams (GPTs) and sub-teams as the Medical Affairs medical expert for the cross functional group
- Providing strategic guidance to scientific communication, external medical education, internal medical training, Medical Information and other functions
- Developing and executing major registration LCM programs and evidence generation activities
- Lead phase 3b/4 clinical studies
- Providing medical review of externally sponsored research and internal proposals, including the review of the Final Report
- Serving as the medical expert and resource in support of the therapeutic area, including content development and medical input into regulatory and safety documents
- Establishing strategic partnerships with centers of excellence and KOLs in areas of scientific interest and serving as conduit for flow of information both out to the medical community and into the company